TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24935984

Group type: EXPERIMENTAL
Intervention: Serum neurofilament light chain (NfL) levels in motor-incomplete SCI (iSCI) patients
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Serum neurofilament light chain (NfL) levels in motor-complete SCI (cSCI) patients
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Serum neurofilament light chain (NfL) levels in central cord syndrome (CCS) patients
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Longitudinal measurement of serum NfL levels
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Correlation of NfL levels with ASIA motor score
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Minocycline treatment in cSCI patients
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Serum NfL concentrations in SCI patients
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Blood NfL levels
Number of subjects: 94
Study: 23663063

Group type: EXPERIMENTAL
Intervention: Low dose (20 Gy) of Gamma knife radiosurgery
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High dose (24 Gy) of Gamma knife radiosurgery
Number of subjects: 24

Group type: COMPARATOR
Intervention: Gamma knife radiosurgery (both doses)
Number of subjects: 24
Study: 21889951

Group type: EXPERIMENTAL
Intervention: Nicotine (6 mg)
Number of subjects: 24
Study: 19819042

Group type: EXPERIMENTAL
Intervention: Cinitapride 1mg oral solution t.i.d for 4 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cinitapride
Number of subjects: 19
Study: 17289910

Group type: EXPERIMENTAL
Intervention: Metabolic alkalosis (Alk)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Con)
Number of subjects: 8
Study: 15326091

Group type: EXPERIMENTAL
Intervention: Nitrendipine (with possible combination or replacement by enalapril, hydrochlorothiazide, or both)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 11684378

Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg daily)
Number of subjects: 66
Study: 9123945

Group type: EXPERIMENTAL
Intervention: 300 mg oral dexibuprofen three times daily
Number of subjects: 110

Group type: COMPARATOR
Intervention: 50 mg oral diclofenac sodium three times daily
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both dexibuprofen and diclofenac sodium
Number of subjects: 110
Study: 7534166

Group type: EXPERIMENTAL
Intervention: Alfuzosin 7.5 mg/day for 30 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 3058538

Group type: EXPERIMENTAL
Intervention: Flupirtine maleate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac sodium
Number of subjects: 40
Study: 31618498

Group type: EXPERIMENTAL
Intervention: Ointment containing Ceratothoa oestroides extract
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ointment containing Ceratothoa oestroides extract and eosin
Number of subjects: 52

Group type: COMPARATOR
Intervention: Ointment containing Ceratothoa oestroides extract and cefaclor
Number of subjects: 52

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 52
Study: 31098654

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFA) 2.2 g/day
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFA)
Number of subjects: 71
Study: 29069156

Group type: EXPERIMENTAL
Intervention: OTC non-hydrogen peroxide bleaching agent (iWhite Instant)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (identically composed product without active agents)
Number of subjects: 40
Study: 25425023

Group type: EXPERIMENTAL
Intervention: Zoledronate administration after radiotherapy (Group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Zoledronate administration prior to radiotherapy (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (radiotherapy only)
Number of subjects: 40
Study: 22947179

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 20009961

Group type: EXPERIMENTAL
Intervention: CEE + progestogen (continuous or cyclical medroxyprogesterone acetate or cyclical micronized progesterone)
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: CEE alone
Number of subjects: 662

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: Strenuous exercise
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: alpha-Tocopherol intake, age, smoking, and alcohol intake
Number of subjects: 662
Study: 18155215

Group type: EXPERIMENTAL
Intervention: Self-trained endoscopists (skilled and trainee)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Self-trained endoscopists (trainee)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Self-trained endoscopists (skilled)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Study patients
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Study patients with previous conventional EGD
Number of subjects: 140

Group type: COMPARATOR
Intervention: Controls (endoscopist skilled in UT‐EGD)
Number of subjects: 140
Study: 16148616

Group type: EXPERIMENTAL
Intervention: Valsartan (160 mg/day) administered at bedtime
Number of subjects: 148

Group type: COMPARATOR
Intervention: Valsartan (160 mg/day) administered in the morning
Number of subjects: 148
Study: 12680160

Group type: EXPERIMENTAL
Intervention: Marimastat 10 mg b.d. for up to two years
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Marimastat with musculoskeletal symptoms
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Marimastat without musculoskeletal symptoms
Number of subjects: 121
Study: 14590216

Group type: EXPERIMENTAL
Intervention: Coached Simulator group
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Uncoached Simulator group
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (optimal performance)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: TBI patients
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Decision rule of > 1 error on subtests I and II
Number of subjects: 92
Study: 8829823

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 253
Study: 1796656

Group type: EXPERIMENTAL
Intervention: Piroxicam (1 x 20 mg daily)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Diclofenac (2 x 50 mg daily)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Indomethacin (3 x 25 mg daily)
Number of subjects: 33
Study: 6880546

Group type: EXPERIMENTAL
Intervention: Regional intravenous sympathetic block with guanethidine (RGB)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no RGB)
Number of subjects: 34
Study: 30883596

Group type: EXPERIMENTAL
Intervention: Carbohydrate intake (0.2 g/kg every 15 minutes) during exercise with bananas (Cavendish, Mini-yellow) and a 6% sugar beverage
Number of subjects: 20

Group type: COMPARATOR
Intervention: Water only (control)
Number of subjects: 20
Study: 27177956

Group type: EXPERIMENTAL
Intervention: Analgesia iv exclusively (Group 1)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Epidural analgesia + analgesia iv (Group 2)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Port-sites infiltration + analgesia iv (Group 3)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (Analgesia iv exclusively)
Number of subjects: 147
Study: 27852723

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 1600

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1600
Study: 24930202

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation exercises (walking, bicycle ergometry, resistance exercises), thrice-weekly for three weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 30
Study: 22552429

Group type: EXPERIMENTAL
Intervention: U-grooved locking compression plate (U-LCP)
Number of subjects: 78

Group type: COMPARATOR
Intervention: LISS
Number of subjects: 78
Study: 20001426

Group type: EXPERIMENTAL
Intervention: Synthetic cannabinoids (nabilone, dronabinol, combination of synthetic Delta9‐THC and cannabidiol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17295293

Group type: EXPERIMENTAL
Intervention: Switching to aminoglutethimide or anastrozole after 2 or 3 years of tamoxifen therapy
Number of subjects: 828

Group type: COMPARATOR
Intervention: Continuing tamoxifen for an additional 2 or 3 years
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Switching to aminoglutethimide or anastrozole
Number of subjects: 828
Study: 15766293

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11900215

Group type: EXPERIMENTAL
Intervention: Long-acting release octreotide pamoate (OP-LAR) plus tamoxifen (TAM)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo plus tamoxifen (TAM)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Long-acting release octreotide pamoate (OP-LAR)
Number of subjects: 203
Study: 12884888

Group type: EXPERIMENTAL
Intervention: Imipramine maintenance treatment (n = 29)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Discontinuation of imipramine (n = 27)
Number of subjects: 56
Study: 7838190

Group type: EXPERIMENTAL
Intervention: 2.5 percent solution of povidone-iodine (n = 1076)
Number of subjects: 3117

Group type: COMPARATOR
Intervention: 1 percent solution of silver nitrate (n = 929)
Number of subjects: 3117

Group type: COMPARATOR
Intervention: 0.5 percent erythromycin ointment (n = 1112)
Number of subjects: 3117
Study: 2323218

Group type: EXPERIMENTAL
Intervention: MLCu-250
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: MLCu-375
Number of subjects: 34
Study: 7350901

Group type: EXPERIMENTAL
Intervention: Choline chloride (16 g)
Number of subjects: 0
Study: 31422215

Group type: EXPERIMENTAL
Intervention: 980-nm/1470-nm dual-wavelength fiber laser surgery
Number of subjects: 44

Group type: COMPARATOR
Intervention: CO2 laser surgery
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 28323625

Group type: EXPERIMENTAL
Intervention: Stretching Training (ST)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no-exercise)
Number of subjects: 24
Study: 23717423

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 220
Study: 21652616

Group type: EXPERIMENTAL
Intervention: i-gel™ with standard Rüsch™ PVC tracheal tube
Number of subjects: 160

Group type: COMPARATOR
Intervention: sILMA™ with single-use ILMA™ tracheal tube
Number of subjects: 160

Group type: COMPARATOR
Intervention: sILMA™
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: i-gel™ and sILMA™
Number of subjects: 160
Study: 19367335

Group type: EXPERIMENTAL
Intervention: Abbreviated counseling (AA)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Standard counseling (SA)
Number of subjects: 278
Study: 16550263

Group type: EXPERIMENTAL
Intervention: HFA‐BDP
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: DPI‐BUD
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 12670672

Group type: EXPERIMENTAL
Intervention: DMSO 50% applied five times daily to the affected extremity
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600mg effervescent tablets three times daily
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 10749011

Group type: EXPERIMENTAL
Intervention: Interactive CD-ROM program designed to teach refusal skills and socially acceptable responses to substance use situations.
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Interactive CD-ROM program
Number of subjects: 74
Study: 9192919

Group type: EXPERIMENTAL
Intervention: Active air-cleaners in living-rooms and bedrooms
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo air-cleaners with allergen-impermeable mattress covers
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Active air-cleaners with allergen-impermeable mattress covers
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Active air-cleaners
Number of subjects: 45
Study: 8466740

Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 mg twice daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nifedipine (20 mg twice daily)
Number of subjects: 25
Study: 3809112

Group type: EXPERIMENTAL
Intervention: Triamcinolone administered to pregnant women
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 5
Study: 29493875

Group type: EXPERIMENTAL
Intervention: Conventional treatment (oxygen, corticosteroids, bronchodilators, physiotherapy) plus one session of sophrology
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 74
Study: 27650009

Group type: EXPERIMENTAL
Intervention: Integrated palliative and respiratory care service
Number of subjects: 20
Study: 24794477

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 80
Study: 22077562

Group type: EXPERIMENTAL
Intervention: Alutard SQ, Phleum pratense 100,000 SQ‐U, 10,000 SQ‐U
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 19788592

Group type: EXPERIMENTAL
Intervention: Daytime supine posture (DSP) study
Number of subjects: 25
Study: 19004402

Group type: EXPERIMENTAL
Intervention: Feminine hygiene wet wipes for 28 days
Number of subjects: 180

Group type: COMPARATOR
Intervention: Dry toilet tissue for 28 days
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Feminine hygiene wet wipes for postmenopausal women
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Feminine hygiene wet wipes for premenopausal women
Number of subjects: 180
Study: 15671131

Group type: EXPERIMENTAL
Intervention: Polysubstance misuse (Ecstasy, amphetamine, cocaine, alcohol, cannabis)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Alcohol/cannabis misuse
Number of subjects: 50
Study: 15566660

Group type: EXPERIMENTAL
Intervention: Sheng Ban Recipe (SBR) plus common treatment
Number of subjects: 103

Group type: COMPARATOR
Intervention: Common treatment alone
Number of subjects: 103
Study: 11414671

Group type: EXPERIMENTAL
Intervention: COSMED K4 b2 portable metabolic measurement system
Number of subjects: 0
Study: 9326685

Group type: EXPERIMENTAL
Intervention: Prefabricated sheath (110 degrees curved tip)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Specially curved sheath (two curves)
Number of subjects: 5
Study: 7951847

Group type: EXPERIMENTAL
Intervention: Omeprazole (OPZ) 20 mg/day
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Omeprazole (OPZ) 20 mg/day plus Pirenzepine (PZP) 100 mg/day
Number of subjects: 44
Study: 3114506

Group type: EXPERIMENTAL
Intervention: Administration sets replaced at 72-hour intervals
Number of subjects: 487

Group type: COMPARATOR
Intervention: Administration sets replaced at 48-hour intervals
Number of subjects: 487
Study: 29253630

Group type: EXPERIMENTAL
Intervention: Presurgery physiotherapy
Number of subjects: 197

Group type: COMPARATOR
Intervention: Waiting-list group (control)
Number of subjects: 197
Study: 26537478

Group type: EXPERIMENTAL
Intervention: L‐T4 administered with breakfast
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: L‐T4 taken 10 min before breakfast
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: L‐T4 administered at 0-10 min intervals before breakfast
Number of subjects: 61

Group type: COMPARATOR
Intervention: L‐T4 taken 30 min before breakfast
Number of subjects: 61
Study: 24664615

Group type: EXPERIMENTAL
Intervention: Diabetes self-management intervention
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 252
Study: 23393185

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) Forced-Flex once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar) once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) Forced-Flex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg) Free-Flex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin degludec (IDeg) and Insulin glargine (IGlar)
Number of subjects: 0
Study: 21122389

Group type: EXPERIMENTAL
Intervention: slow-release 5-fluorouracil implantation
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study: 18414107

Group type: EXPERIMENTAL
Intervention: Bimatoprost/timolol fixed combination (FC)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Bimatoprost (BIM)
Number of subjects: 1061

Group type: COMPARATOR
Intervention: Timolol (TIM)
Number of subjects: 1061
Study: 16586071

Group type: COMPARATOR
Intervention: Natural interferon-alpha alone
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Natural interferon-alpha plus cimetidine
Number of subjects: 71
Study: 12730285

Group type: EXPERIMENTAL
Intervention: Adolescent siblings of childhood cancer survivors
Number of subjects: 78
Study: 10781460

Group type: EXPERIMENTAL
Intervention: Clonidine 1 microg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Morphine 3 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of clonidine 1 microg/kg and morphine 3 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine 0.25%
Number of subjects: 60
Study: 8624003

Group type: EXPERIMENTAL
Intervention: Rocuronium initial dose of 144 micrograms.kg‐1 in cirrhotic patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rocuronium initial dose of 60 micrograms.kg‐1 in control subjects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Maintenance doses of 75, 150, or 225 micrograms.kg‐1 administered at 25% recovery of twitch height in cirrhotic patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Maintenance doses of 75, 150, or 225 micrograms.kg‐1 administered at 25% recovery of twitch height in control subjects
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rocuronium in cirrhotic patients receiving five maintenance doses or more
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rocuronium in cirrhotic patients
Number of subjects: 50

Group type: COMPARATOR
Intervention: Rocuronium in control subjects
Number of subjects: 50
Study: 1410233

Group type: EXPERIMENTAL
Intervention: Various biomedical, behavioral, and environmental interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life measures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Common measures of quality of life
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preliminary observations from FICSIT
Number of subjects: 0
Study: 3993154

Group type: EXPERIMENTAL
Intervention: L-penbutolol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: D-penbutolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29995952

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice supplementation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 12
Study: 26794682

Group type: EXPERIMENTAL
Intervention: Dasotraline 8 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dasotraline 16 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dasotraline 36 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 40 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 80 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 24088915

Group type: EXPERIMENTAL
Intervention: PEEP=5 cmH2O (Group A)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: PEEP=8 cmH2O (Group B)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: PEEP=10 cmH2O (Group C)
Number of subjects: 136
Study: 22892804

Group type: EXPERIMENTAL
Intervention: Semont maneuver
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 128
Study: 20937127

Group type: EXPERIMENTAL
Intervention: Minocycline 100 mg or 200 mg daily
Number of subjects: 20
Study: 18538109

Group type: EXPERIMENTAL
Intervention: CR002 (0.3, 1, 3, 10, 30 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CR002
Number of subjects: 40
Study: 16203881

Group type: EXPERIMENTAL
Intervention: Long-stem cementless calcar-replacement prosthesis
Number of subjects: 58

Group type: COMPARATOR
Intervention: Proximal femoral nail
Number of subjects: 58
Study: 12701733

Group type: EXPERIMENTAL
Intervention: Ipsilateral 45 dB HL 250 Hz narrow-band noise (NBN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Contralateral 45 dB HL 250 Hz narrow-band noise (NBN)
Number of subjects: 16

Group type: COMPARATOR
Intervention: 90 dB HL 2 kHz pure tone
Number of subjects: 16
Study: 10337860

Group type: EXPERIMENTAL
Intervention: Exercise and alcohol (0.4 g/kg body weight)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Exercise alone (30 minutes at 40% VO2max)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Resting state
Number of subjects: 23

Group type: COMPARATOR
Intervention: Alcohol alone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Alcohol intake
Number of subjects: 23
Study: 10142127

Group type: EXPERIMENTAL
Intervention: Consumer case managers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonconsumer case managers
Number of subjects: 0
Study: 2143593

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (360 micrograms total, 60 micrograms into each nostril, repeated twice at 15 min intervals)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (age‐sex matched subjects)
Number of subjects: 20
Study: 7299611

Group type: EXPERIMENTAL
Intervention: Triple instillation of aqueous phenylephrine 2.5% and tropicamide 1.0%
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Single instillation of phenylephrine 2.5%, tropicamide 0.5%, and cyclogyl 0.5%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Balanced salt solution (placebo)
Number of subjects: 52
Study: 31422879

Group type: EXPERIMENTAL
Intervention: Dexrazoxane-Anthracyclines association
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 20